Growing the future. Trusted medicinal cannabis.

At Chilam, we are delivering a bright future for patients and fostering a healthier community around the world. We believe in the power of the plant and have experienced first-hand its medicinal properties. We are on a mission to leverage this.

In addition to cultivating, growing and processing high-quality medicinal cannabis, our focus will be on developing and delivering products to market that dramatically enhance the quality of life, particularly for patients suffering from chronic pain and disease.

Chilam is fully licenced in North Macedonia. The country's aim is to become Europe’s "Cannabis Superpower" setting itself as a globally competitive country, set to dominate in the worldwide market.

We leverage the ideal climate and low-cost cannabis production & jurisdiction with our strong expertise and technology to produce an industry-leading product.

Chilam has partnered with industry experienced construction, genetics, cultivation and medicinal consultants & specialists to ensure the delivery of a best-in-class EU GMP and GACP compliant pharmaceutical-grade ingredient for the medicinal market.

Our 20,000 sqm state-of-the-art facility in North Macedonia is supporting the entire manufacturing lifecycle, with a focus on quality controls, analytical test lab, bulk extract and white-label production.

A full range of cannabis extracts.

Chilam cultivates and produces a full spectrum of dried cannabis products and extracted cannabis oil with full profile terpenes.

Available as cured and trimmed whole cannabis flower or formulated extracts, highly-purified cannabinoid isolates or blended Active Pharmaceutical Ingredients (API) are offered for pharmaceutical drug development programs and commercial manufacturers.

Our state-of-the-art laboratory has been designed to ensure all products adhere to all compliance for imports in target markets.

By establishing good agricultural and collection practice for cannabis materials(GACP) as well as Good Manufacturing Practice (GMP) for the manufacture, processing, bottling and storage of Active Pharmaceutical Ingredients (APIs), we're driven to provide appropriate and consistent quality of medicinal cannabis.

From genetics and vertical farming experts to storied cannabis growers, pharmaceutical manufacturers and tech icons, our accomplishments to date are a result of our diversity. Chilam’s Board and Leadership team have extensive knowledge in setting up, growing and scaling of globally recognized companies, the cannabis and pharmaceutical industry and legislation, real-estate and technology. Our team also has a proven track record of operating successful North Macedonian entities.

Chilam is driven by an experienced management team who value expertise, along with capability. The team brings together a team of diverse minds who drive each other to create change and deliver innovation.

• North Macedonia legalised the licensed production of medicinal cannabis products in 2016
• It has existing European export agreements for the distribution of GMP medicinal cannabis products
• Highly cost-effective production and operations
• Rated in the top 10 countries to do business in 2019 by the World Bank and for the protection of foreign investments
• Favourable taxation rate of 10%